维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="Bryzinski"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovas- cular disease history or cardiovascular risk factors: Results of a pooled analysis of phase 3 clinical trials显示文摘	Cook W Bryzinski B Slater J	2013	Postgrad Med2013，125，3：	1
	2	Saxagliptin efficacy andsafety in patients with type 2 diabetes mellitus and cardiovas-cular disease history or cardiovascular risk factors: Results of apooled analysis of phase 3 clinical trials 显示文摘	Cook W Bryzinski B Slater J	2013	Postgrad Med2013，125，3：	1
	3	Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors : analysis of 3 clinical trials 显示文摘	Cook W Minervini G Bryzinski B	2014	Postgrad Med2014，126，6：	1
	4	Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial显示文摘	James M. McKenney Peter H. Jones M. Angeli Adamczyk Valerie A. Cain Brian S. Bryzinski James W. Blasetto	2003	2003，，8：	1
	5	Saxagliptin efficacy and safety in patients with type 2diabetes mellitus and cardiovascular disease history or cardiovascular risk factors:results of a pooled analysis of phase 3clinical trials显示文摘	Cook W Bryzinski B Slater J	2013	Postgrad Med2013，125，3：	1
	6	Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardio- vascular disease history orardiovaseular risk factors: resuhs of a pooled analysis of phase 3 clinical lrials 显示文摘	COOK W BRYZINSKI B SLATER J	2013	Postgrad Med2013，125，3：	1
	7	Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovasc, ular disease history or cardiovascular risk fac- tors : resuhs of a pooled analysis of phase 3 clinical trials 显示文摘	Cook W Bryzinski B Slater J	2013	Postgrad Med2013，125，3：	1
	8	Saxagliptin effica- cy and safety in patients with type 2 diabetes receiving concomitant statin therapy 显示文摘	Bryzinski B Allen E Cook W	2014	J Diabetes Complica- tions2014，28，6：	1
	9	Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovas- cular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials显示文摘	Cook W Bryzinski B Slater J	2013	Postgrad Med2013，125，3：	1
	10	A maltifactroial design to assess combination therapy in hypertension显示文摘	Frishman WH Bryzinski BS Conlson LR		0，，：	1
	11	A Multifactrial design to assess combination therapy in hypertension显示文摘	Frishman WH Bryzinski BS Conlson LR	1994	Arch Intern Med1994，154，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费